← Find a medication
Other Specialties

Embeda

Generic: morphine sulfate and naltrexone hydrochloride

Manufacturer: Pfizer  ·  Program:

Apply for assistance

Free to apply. Service from $40/month, payable only when your application is ready to submit.

Eligibility Criteria

Insurance Requirement

See program details

Residency

US residency required

Income Threshold

Up to 300% FPL

Individual Income Limit

$43,740/year

Must be uninsured or publicly insured; commercial insurance ineligible

Program Information

Processing Time

2–4 weeks after complete application received

Delivery Method

shipped to patient

Application Method

Multiple

Indicated for

chronic pain

About This Medication

Pfizer Patient Assistance Program Guide: How to Get Embeda at Low or No Cost

Important Notice: Embeda (morphine sulfate and naltrexone hydrochloride) has been discontinued in the United States.[6] This guide provides general information on Pfizer's patient assistance programs for reference, but availability of Embeda specifically may be limited or unavailable. Consult your healthcare provider or pharmacist for current alternatives and options.

About Embeda

Embeda is an extended-release capsule combining morphine sulfate, a narcotic pain reliever that acts on the central nervous system to manage moderate to severe pain, and naltrexone hydrochloride, an opioid antagonist designed to deter abuse.[2][4][5] It is indicated for pain severe enough to require daily, around-the-clock, long-term opioid treatment when alternative options are inadequate—not for as-needed use.[3][5]

The naltrexone remains sequestered when taken as directed but releases if crushed, potentially blocking morphine's effects and precipitating withdrawal in opioid-dependent individuals.[2][7] Embeda carries black box warnings for addiction, abuse, misuse, life-threatening respiratory depression, and neonatal opioid withdrawal syndrome.[3][5] Common side effects include sleepiness, dizziness, and constipation.[6] Patients must follow the Opioid Analgesic REMS program to prevent addiction risks.[4]

Dosing starts at one 20 mg/0.8 mg capsule daily for opioid-naïve patients, with adjustments based on tolerance.[5] Higher doses (e.g., 100 mg/4 mg) are only for opioid-tolerant patients.[5]

Who Qualifies for Pfizer's Patient Assistance Program?

Pfizer offers patient assistance programs like Pfizer Patient Assistance Program (PPAP) and RxPathways to help uninsured or underinsured U.S. residents access medications at low or no cost. Eligibility typically targets those with household incomes at or below 400% of the Federal Poverty Level (FPL), though exact thresholds vary and should be verified directly with Pfizer.[Special:General Pfizer knowledge]

Qualifying patients generally include:

  • U.S. citizens, residents, or legal aliens.
  • Uninsured or Medicare patients without prescription coverage (private insurance often ineligible).
  • Household income meeting FPL guidelines.
  • Valid prescription for an approved Pfizer medication (note Embeda's discontinuation).[6]

Income Eligibility Breakdown

Specific income thresholds for Embeda are not detailed in current sources, as the program details are unavailable. Below is a general table based on typical Pfizer programs at 400% FPL (2026 estimates; confirm current FPL at benefits.gov). Use Pfizer's eligibility tool for precise figures.

Household SizeAnnual Income Limit (400% FPL)
1 (Individual)$60,320
2 (Couple)$81,760
3$103,200
4$124,640

Notes: Add ~$21,440 per additional person. Income includes all household taxable income. Assets may be considered. Medicare Part D enrollees may qualify via Pfizer RxPathways if in the coverage gap.[Special:General knowledge]

Insurance Requirements

Patients with private insurance typically do not qualify, as Pfizer programs prioritize the uninsured or those with inadequate coverage. Medicare patients without supplemental drug coverage or in the 'donut hole' may be eligible through specific pathways. Do not enroll if you participate in Medicaid or similar federal/state programs.[Special:General Pfizer knowledge]

Step-by-Step Application Process

  1. Confirm Eligibility: Visit Pfizer's website (pfizerpatientassistance.com) or call 1-844-989-7284 (RxPathways) to check if Embeda or alternatives qualify.[Special:General]
  2. Gather Documents: Prepare proof of income (tax returns, pay stubs, W-2s), proof of residency, prescription, and insurance status (if any).[Special:General]
  3. Get Doctor's Sign-Off: Have your physician complete the application, confirming medical necessity.
  4. Submit Application: Apply online, by phone, or mail. Digital upload preferred for speed.[Special:General]
  5. Follow Up: Track status via portal or phone.

Timeline and Delivery

Processing typically takes 2-4 weeks after complete submission.[Special:General] Approved medication ships directly to your doctor's office or home via mail. Expect free shipping; refills auto-ship if enrolled.

Alternatives if Denied or Unavailable

Since Embeda is discontinued,[6] consider FDA-approved abuse-deterrent opioids like other extended-release morphine formulations or alternatives (e.g., oxycodone ER). Explore:

  • NeedyMeds or RxAssist for aggregators.
  • Pfizer's other programs for similar drugs.
  • State pharmaceutical assistance or 711 programs for Medicare.
  • Non-opioid options per your doctor's advice.[3]

Contact SAMHSA Helpline (1-800-662-HELP) for substance use support.[1]

Disclaimer

This guide is for informational purposes only and not medical or legal advice. Program details change; verify with Pfizer directly. Embeda's discontinuation means limited access—discuss with your healthcare provider. Risks of opioids are serious; use only as prescribed. Word count: 942.

Program information last verified: March 30, 2026

Ready to apply for Embeda assistance?

ProvisionRX manages the complete application process. Start your application in about 15 minutes.

Start My ApplicationBrowse All Medications

Need help finding a program?